EvaluatePharma

www.evaluatepharma.com

11-29 Fashion Street
London
E1 6PX
United Kingdom

+44 207 377 0800

Activities

Media

Related Companies

Related Content

Worldwide prescription drug sales accelerate to $1.2 trillion by 2024
Worldwide prescription drug sales accelerate to $1.2 trillion by 2024
What’s in store for 2018 in the pharma and biotech industry?
What’s in store for 2018 in the pharma and biotech industry?
Japanese pharmaceutical market set to grow
Japanese pharmaceutical market set to grow
Pricing pressure causes worldwide drug sales forecasts to fall for first time in 10 years
Pricing pressure causes worldwide drug sales forecasts to fall for first time in 10 years
Worldwide prescription drug sales to top trillion dollar mark in 2022
Worldwide prescription drug sales to top trillion dollar mark in 2022
Orphan drug market growing, despite high costs
Orphan drug market growing, despite high costs
Worldwide prescription drug sales forecast to grow 6.3%
Worldwide prescription drug sales forecast to grow 6.3%
European pharma market projected to grow from €169bn in 2015 to €206bn in 2022
European pharma market projected to grow from €169bn in 2015 to €206bn in 2022
Per patient costs for orphan drugs are 13.8 times higher than non-orphan drugs
Per patient costs for orphan drugs are 13.8 times higher than non-orphan drugs
UK life sciences funding reaches 10-year high, finds report
UK life sciences funding reaches 10-year high, finds report
Orphan drug market expected to reach US$176bn by 2020
Orphan drug market expected to reach US$176bn by 2020
Alexander Karle becomes CEO of Evaluate
Alexander Karle becomes CEO of Evaluate
Orphan drug market to reach US$127bn by 2018, says Evaluate report
Orphan drug market to reach US$127bn by 2018, says Evaluate report
Worldwide orphan drug market to reach US$127bn by 2018
Worldwide orphan drug market to reach US$127bn by 2018